Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Ringe

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Der Internist|June 4, 1999
[Rheumatology]E Genth, G R Burmester, W L Gross, et al.
Unfallchirurgie|October 1, 1981
[The influence of cyclophosphamide upon the healing of fractures in the rabbit (author's transl)]H U Langendorff, H D Sauer, H Schöttle, et al.
Deutsche Medizinische Wochenschrift (1946)|September 18, 1987
[Percutaneous transthyroidal instillation treatment of parathyroid adenoma with ethanol in primary hyperparathyroidism]H W Müller-Gärtner, F U Beil, C Schneider, et al.
Revue Du Rhumatisme (English Ed.)|April 1, 1997
Optimizing the treatment of Paget's disease of boneJ Y Reginster, C Gennari, D J Hosking, et al.
Rheumatology International|March 17, 2005
Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot studyJ D Ringe, A Dorst, H Faber, et al.
Zeitschrift Fur Rheumatologie|July 1, 1996
[Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans]J D Ringe, J Y Reginster, C Gennari, et al.
Current Medical Research and Opinion|September 22, 2007
Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal womenJ D Ringe, G E Christodoulakos, D Mellström, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 28, 2012
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practiceT Thomas, S Horlait, J D Ringe, et al.
Rheumatology International|September 7, 2002
Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosisJ D Ringe, H Faber, O Bock, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 20, 2009
Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosisD L Kendler, J D Ringe, L-G Ste-Marie, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Der Internist|June 4, 1999
[Rheumatology]E Genth, G R Burmester, W L Gross, et al.
Unfallchirurgie|October 1, 1981
[The influence of cyclophosphamide upon the healing of fractures in the rabbit (author's transl)]H U Langendorff, H D Sauer, H Schöttle, et al.
Deutsche Medizinische Wochenschrift (1946)|September 18, 1987
[Percutaneous transthyroidal instillation treatment of parathyroid adenoma with ethanol in primary hyperparathyroidism]H W Müller-Gärtner, F U Beil, C Schneider, et al.
Revue Du Rhumatisme (English Ed.)|April 1, 1997
Optimizing the treatment of Paget's disease of boneJ Y Reginster, C Gennari, D J Hosking, et al.
Rheumatology International|March 17, 2005
Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot studyJ D Ringe, A Dorst, H Faber, et al.
Zeitschrift Fur Rheumatologie|July 1, 1996
[Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans]J D Ringe, J Y Reginster, C Gennari, et al.
Current Medical Research and Opinion|September 22, 2007
Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal womenJ D Ringe, G E Christodoulakos, D Mellström, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 28, 2012
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practiceT Thomas, S Horlait, J D Ringe, et al.
Rheumatology International|September 7, 2002
Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosisJ D Ringe, H Faber, O Bock, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 20, 2009
Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosisD L Kendler, J D Ringe, L-G Ste-Marie, et al.
Pageof 16